In further studies, we warranted to determine the bioavailability of the active entity, and evaluate the mechanisms by which polyphenolic mediates AMPK/SREBP/ACC and IRs-1/Akt in HFD-induced NAFLD. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.